Distress Management: Clinical practice guidelines in oncology

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 11, Issue 2, 2013, Pages 190-209

  Holland, Jimmie C ^a   Andersen, Barbara ^b   Breitbart, William S ^a   Buchmann, Luke O ^c   Compas, Bruce ^d   Deshields, Teresa L ^e   Dudley, Moreen M ^f   Fleishman, Stewart ^g   Fulcher, Caryl D ^h   Greenberg, Donna B ⁱ   Greiner, Carl B ^j   Handzo, Rev George F ^x   Hoofring, Laura ^k   Hoover, Charles ^x   Jacobsen, Paul B ^l   Kvale, Elizabeth ^m   Levy, Michael H ⁿ   Loscalzo, Matthew J ^o   Randi McAllister Black, ^o   Mechanic, Karen Y ⁿ   Palesh, Oxana ^p   Pazar, Janice P ^q   Riba, Michelle B ^r   Roper, Kristin ^s   Valentine, Alan D ^t   Wagner, Lynne I ^u   Zevon, Michael A ^v   McMillian, Nicole R ^w   Freedman Cass, Deborah A ^w   more..

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

^e BARNES JEWISH HOSPITAL   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g Beth Israel Cancer Center   (United States)

^h DUKE CANCER INSTITUTE   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^j NEBRASKA MEDICAL CENTER   (United States)

^k JOHNS HOPKINS UNIVERSITY   (United States)

^l H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^m UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁿ FOX CHASE CANCER CENTER   (United States)

^o CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^p STANFORD CANCER INSTITUTE   (United States)

^q UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^r UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^s Dana Farber Brigham and Women's Cancer Center   (United States)

^t UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^u NORTHWESTERN UNIVERSITY   (United States)

^v ROSWELL PARK CANCER INSTITUTE   (United States)

^w NCCN   (United States)

^x NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ARTICLE; BECK DEPRESSION INVENTORY; BREAST CANCER; BURNOUT; CANCER PATIENT; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COGNITIVE DEFECT; CONCENTRATION LOSS; COUNSELING; DECREASED APPETITE; DEPRESSION; DISTRESS SYNDROME; DISTRESS THERMOMETER; EARLY DIAGNOSIS; EXERCISE; FERTILITY; GYNECOLOGIC CANCER; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LUNG CANCER; MENTAL HEALTH SERVICE; META ANALYSIS (TOPIC); OVERALL SURVIVAL; PATIENT EDUCATION; PATIENT REFERRAL; PRACTICE GUIDELINE; PSYCHOSOCIAL CARE; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; RECURRENT CANCER; RELAXATION TRAINING; SEXUAL ABUSE; SLEEP DISORDER; SOCIAL WORK; SPIRITUAL CARE; SUBSTANCE ABUSE; SUPPORT GROUP; CLINICAL TRIAL (TOPIC); MENTAL STRESS; NEOPLASM; ONCOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; STANDARD;

CLINICAL TRIALS AS TOPIC; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; STRESS, PSYCHOLOGICAL;

EID: 84874633075     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2013.0027     Document Type: Article

References (107)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Carr D, Goudas L, Lawrence D, et al. Management of Cancer Symptoms: Pain, Depression, and Fatigue. Evidence Report/Technology Assessment No. 61 (Prepared by the New England Medical Center Evidence-based Practice Center under Contract No 290-97-0019). AHRQ Publication No. 02-E032. Rockville, MD: Agency for Healthcare Research and Quality. July 2002. Available at: http://archive.ahrq. gov/downloads/pub/evidence/pdf/cansymp/cansymp.pdf. Accessed January 9, 2013.
3. Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003;97:2919-2925.
4. Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56.
5. Miller K, Massie MJ. Depression and anxiety. Cancer J 2006;12:388-397.
6. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004;5:617-625.
7. Zabora J, BrintzenhofeSzoc K, Curbow B, et al. The prevalence of psychological distress by cancer site. Psychooncology 2001;10:19-28.
8. Carlsen K, Jensen AB, Jacobsen E, et al. Psychosocial aspects of lung cancer. Lung Cancer 2005;47:293-300.
9. Derogatis LR, Morrow GR, Fetting J, et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983;249:751-757.
10. Hegel MT, Moore CP, Collins ED, et al. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer 2006;107:2924-2931.
11. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003;54:269-282.
12. Holland JC, Alici Y. Management of distress in cancer patients. J Support Oncol 2010;8:4-12.
13. Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 2012;141:343-351.
14. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004:57-71.
15. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011;12:160-174.
16. Partridge AH, Wang PS, Winer EP, Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003;21:602-606.
17. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-2107.
18. Bultz BD, Holland JC. Emotional distress in patients with cancer: the sixth vital sign. Commun Oncol 2006;3:311-314.
19. Carlson LE, Bultz BD. Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psychooncology 2004;13:837-849; discussion 850-836.
20. Brown KW, Levy AR, Rosberger Z, Edgar L. Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med 2003;65:636-643.
21. Kissane D. Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psychooncology 2009;18:1-5.
22. Carmack CL, Basen-Engquist K, Gritz ER. Survivors at higher risk for adverse late outcomes due to psychosocial and behavioral risk factors. Cancer Epidemiol Biomarkers Prev 2011;20:2068-2077.
23. Carlson LE, Bultz BD. Cancer distress screening. Needs, models, and methods. J Psychosom Res 2003;55:403-409.
24. Zabora JR. Screening procedures for psychosocial distress. In: Holland JC, Breitbart W, Jacobsen PB, et al, eds. Psycho Oncology. New York, NY: Oxford University Press; 1998:653-661.
25. Carlson LE, Groff SL, Maciejewski O, Bultz BD. Screening for distress in lung and breast cancer outpatients: a randomized controlled trial. J Clin Oncol 2010;28:4884-4891.
26. Spiegel D. Mind matters in cancer survival. Psychooncology 2012;21:588-593.
27. Kadan-Lottick NS, Vanderwerker LC, Block SD, et al. Psychiatric disorders and mental health service use in patients with advanced cancer: a report from the coping with cancer study. Cancer 2005;104:2872-2881.
28. Sharpe M, Strong V, Allen K, et al. Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer 2004;90:314-320.
29. Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001;84:1011-1015.
30. Holland JC. American Cancer Society Award lecture. Psychological care of patients: psycho-oncology's contribution. J Clin Oncol 2003;21:253s-265s.
31. Fitchett G, Handzo G. Spiritual assessment, screening, and intervention. In: Holland JC, Breitbart W, Jacobsen PB, et al, eds. Psycho Oncology. New York: Oxford University Press; 1998:790-808.
32. Holland JC, Greenberg DB, Hughes MK. Quick Reference for Oncology Clinicians: The Psychiatric and Psychological Dimensions of Cancer Symptom Management. Charlottesville, VA: IPOS press; 2006.
33. Holland JC, Andersen B, Breitbart WS, et al. Distress management. J Natl Compr Canc Netw 2010;8:448-485.
34. Adler NE, Page NE, eds. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington, DC: National Academies Press; 2008.
35. Jacobsen PB, Jim HS. Psychosocial interventions for anxiety and depression in adult cancer patients: achievements and challenges. CA Cancer J Clin 2008;58:214-230.
36. Bultz BD, Carlson LE. Emotional distress: the sixth vital sign in cancer care. J Clin Oncol 2005;23:6440-6441.
37. Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee. JAMA 1995;274:1874-1880.
38. Jacobsen PB, Ransom S. Implementation of NCCN Distress Management Guidelines by member institutions. J Natl Compr Canc Netw 2007;5:99-103.
39. Jacobsen PB. Promoting evidence-based psychosocial care for cancer patients. Psychooncology 2009;18:6-13.
40. Neuss MN, Desch CE, McNiff KK, et al. A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative. J Clin Oncol 2005;23:6233-6239.
41. Jacobson JO, Neuss MN, McNiff KK, et al. Improvement in oncology practice performance through voluntary participation in the Quality Oncology Practice Initiative. J Clin Oncol 2008;26:1893-1898.
42. Blayney DW, McNiff K, Hanauer D, et al. Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center. J Clin Oncol 2009;27:3802-3807.
43. Jacobsen PB. Improving psychosocial care in outpatient oncology settings. J Natl Compr Canc Netw 2010;8:368-370.
44. Rodriguez MA, Tortorella F, St John C. Improving psychosocial care for improved health outcomes. J Healthc Qual 2010;32:3-12.
45. Frost GW, Zevon MA, Gruber M, Scrivani RA. Use of distress thermometers in an outpatient oncology setting. Health Soc Work 2011;36:293-297.
46. Fulcher CD, Gosselin-Acomb TK. Distress assessment: practice change through guideline implementation. Clin J Oncol Nurs 2007;11:817-821.
47. Hendrick SS, Cobos E. Practical model for psychosocial care. J Oncol Pract 2010;6:34-36.
48. Loscalzo M, Clark KL, Holland J. Successful strategies for implementing biopsychosocial screening. Psychooncology 2011;20:455-462.
49. Mehta A, Hamel M. The development and impact of a new Psychosocial Oncology Program. Support Care Cancer 2011;19:1873-1877.
50. Carlson LE, Waller A, Mitchell AJ. Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol 2012;30:1160-1177.
51. Fann JR, Ell K, Sharpe M. Integrating psychosocial care into cancer services. J Clin Oncol 2012;30:1178-1186.
52. Lowery AE, Holland JC. Screening cancer patients for distress: guidelines for routine implementation. Community Oncol 2011;8:502-505.
53. Bultz BD, Groff SL, Fitch M, et al. Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psychooncology 2011;20:463-469.
54. Dolbeault S, Boistard B, Meuric J, et al. Screening for distress and supportive care needs during the initial phase of the care process: a qualitative description of a clinical pilot experiment in a French cancer center. Psychooncology 2011;20:585-593.
55. Grassi L, Rossi E, Caruso R, et al. Educational intervention in cancer outpatient clinics on routine screening for emotional distress: an observational study. Psychooncology 2011;20:669-674.
56. Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol 2007;25:4670-4681.
57. Zabora J, BrintzenhofeSzoc K, Jacobsen P, et al. A new psychosocial screening instrument for use with cancer patients. Psychosomatics 2001;42:241-246.
58. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
59. Mitchell AJ, Kaar S, Coggan C, Herdman J. Acceptability of common screening methods used to detect distress and related mood disorders-preferences of cancer specialists and non-specialists. Psychooncology 2008;17:226-236.
60. Mitchell AJ. Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis. J Natl Compr Canc Netw 2010;8:487-494.
61. Carlson LE, Waller A, Groff SL, et al. Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomised controlled trial of computerised vs personalised triage. Br J Cancer 2012;107:617-625.
62. Loscalzo M, Clark K, Dillehunt J, et al. Support Screen: a model for improving patient outcomes. J Natl Compr Canc Netw 2010;8:496-504.
63. Miller MF, Buzaglo JS, Clark KL, et al. Demonstrating the psychometric properties of a problem-related distress screener in a community sample of 319 cancer survivors. Psychooncology, in press.
64. Mitchell AJ, Meader N, Davies E, et al. Meta-analysis of screening and case finding tools for depression in cancer: evidence based recommendations for clinical practice on behalf of the Depression in Cancer Care consensus group. J Affect Disord 2012;140:149-160.
65. Akizuki N, Akechi T, Nakanishi T, et al. Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer 2003;97:2605-2613.
66. Dabrowski M, Boucher K, Ward JH, et al. Clinical experience with the NCCN Distress Thermometer in breast cancer patients. J Natl Compr Canc Netw 2007;5:104-111.
67. Hoffman BM, Zevon MA, D'Arrigo MC, Cecchini TB. Screening for distress in cancer patients: the NCCN rapid-screening measure. Psychooncology 2004;13:792-799.
68. Jacobsen PB, Donovan KA, Trask PC, et al. Screening for psychologic distress in ambulatory cancer patients. Cancer 2005;103:1494-1502.
69. Patrick-Miller LJ, Broccoli TL, Much JK, Levine E. Validation of the Distress Thermometer: a single item screen to detect clinically significant psychological distress in ambulatory oncology patients [abstract]. J Clin Oncol 2004;22(Suppl 14):Abstract 6024.
70. Roth AJ, Kornblith AB, Batel-Copel L, et al. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 1998;82:1904-1908.
71. Zwahlen D, Hagenbuch N, Carley MI, et al. Screening cancer patients' families with the distress thermometer (DT): a validation study. Psychooncology 2008;17:959-966.
72. Graves KD, Arnold SM, Love CL, et al. Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress. Lung Cancer 2007;55:215-224.
73. Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE. Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer. Cancer 2008;113:870-878.
74. Ransom S, Jacobsen PB, Booth-Jones M. Validation of the Distress Thermometer with bone marrow transplant patients. Psychooncology 2006;15:604-612.
75. Trask PC, Paterson A, Riba M, et al. Assessment of psychological distress in prospective bone marrow transplant patients. Bone Marrow Transplant 2002;29:917-925.
76. Janelsins MC, Kohli S, Mohile SG, et al. An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol 2011;38:431-438.
77. Wefel JS, Vardy J, Ahles T, Schagen SB. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 2011;12:703-708.
78. Anderson-Hanley C, Sherman ML, Riggs R, et al. Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 2003;9:967-982.
79. Deprez S, Amant F, Smeets A, et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol 2012;30:274-281.
80. Stewart A, Bielajew C, Collins B, et al. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 2006;20:76-89.
81. Vardy J, Rourke S, Tannock IF. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 2007;25:2455-2463.
82. Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 2007;7:192-201.
83. Ahles TA, Saykin AJ, McDonald BC, et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat 2008;110:143-152.
84. Ahles TA, Saykin AJ, McDonald BC, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 2010;28:4434-4440.
85. Wefel JS, Lenzi R, Theriault R, et al. 'Chemobrain' in breast carcinoma?: a prologue. Cancer 2004;101:466-475.
86. Wefel JS, Lenzi R, Theriault RL, et al. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 2004;100:2292-2299.
87. Jean-Pierre P, Winters PC, Ahles TA, et al. Prevalence of self-reported memory problems in adult cancer survivors: a national cross-sectional study. J Oncol Pract 2012;8:30-34.
88. Nelson CJ, Nandy N, Roth AJ. Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliat Support Care 2007;5:273-280.
89. Ferguson RJ, McDonald BC, Rocque MA, et al. Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial. Psychooncology 2012;21:176-186.
90. Gehring K, Roukema JA, Sitskoorn MM. Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Rev Anticancer Ther 2012;12:255-269.
91. Kohli S, Fisher SG, Tra Y, et al. The effect of modafinil on cognitive function in breast cancer survivors. Cancer 2009;115:2605-2616.
92. Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 1998;16:2522-2527.
93. Sood A, Barton DL, Loprinzi CL. Use of methylphenidate in patients with cancer. Am J Hosp Palliat Care 2006;23:35-40.
94. Shaw EG, Rosdhal R, D'Agostino RB Jr, et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 2006;24:1415-1420.
95. Vardy J, Wefel JS, Ahles T, et al. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008;19:623-629.
96. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917-2931.
97. Shanafelt T, Dyrbye L. Oncologist burnout: causes, consequences, and responses. J Clin Oncol 2012;30:1235-1241.
98. Jacobsen PB, Wagner LI. A new quality standard: the integration of psychosocial care into routine cancer care. J Clin Oncol 2012;30:1154-1159.
99. Jacobsen PB, Holland JC, Steensma DP. Caring for the whole patient: the science of psychosocial care. J Clin Oncol 2012;30:1151-1153.
100. Breitbart W, Alici Y. Evidence-based treatment of delirium in patients with cancer. J Clin Oncol 2012;30:1206-1214.
101. Li M, Fitzgerald P, Rodin G. Evidence-based treatment of depression in patients with cancer. J Clin Oncol 2012;30:1187-1196.
102. Traeger L, Greer JA, Fernandez-Robles C, et al. Evidence-based treatment of anxiety in patients with cancer. J Clin Oncol 2012;30:1197-1205.
103. Stanton AL. What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol 2012;30:1215-1220.
104. Zebrack B, Isaacson S. Psychosocial care of adolescent and young adult patients with cancer and survivors. J Clin Oncol 2012;30:1221-1226.
105. Northouse L, Williams AL, Given B, McCorkle R. Psychosocial care for family caregivers of patients with cancer. J Clin Oncol 2012;30:1227-1234.
106. Kissane DW, Bylund CL, Banerjee SC, et al. Communication skills training for oncology professionals. J Clin Oncol 2012;30:1242-1247.
107. Holland JC, Bultz BD. The NCCN Guideline for Distress Management: a case for making distress the sixth vital sign. J Natl Compr Canc Netw 2007;5:3-7.